MYC and triple-negative breast carcinoma: However, recent identification of CIP2A as a central DNA damage response (DDR) protein essential for BRCA-mutated triple-negative breast cancer (TNBC) cells24,26, indicates that CIP2A has broader role in cancer beyond MYC regulation.